BioLargo Shares Outstanding 2010-2025 | BLGO
BioLargo shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
BioLargo Annual Shares Outstanding
(Millions of Shares) |
| 2024 |
298 |
| 2023 |
286 |
| 2022 |
268 |
| 2021 |
247 |
| 2020 |
196 |
| 2019 |
152 |
| 2018 |
122 |
| 2017 |
99 |
| 2016 |
88 |
| 2015 |
84 |
| 2014 |
80 |
| 2013 |
73 |
| 2012 |
64 |
| 2011 |
56 |
| 2010 |
46 |
| 2009 |
43 |
BioLargo Quarterly Shares Outstanding
(Millions of Shares) |
| 2025-03-31 |
301 |
| 2024-12-31 |
298 |
| 2024-09-30 |
300 |
| 2024-06-30 |
296 |
| 2024-03-31 |
294 |
| 2023-12-31 |
286 |
| 2023-09-30 |
288 |
| 2023-06-30 |
285 |
| 2023-03-31 |
281 |
| 2022-12-31 |
268 |
| 2022-09-30 |
271 |
| 2022-06-30 |
266 |
| 2022-03-31 |
261 |
| 2021-12-31 |
247 |
| 2021-09-30 |
253 |
| 2021-06-30 |
244 |
| 2021-03-31 |
234 |
| 2020-12-31 |
196 |
| 2020-09-30 |
210 |
| 2020-06-30 |
182 |
| 2020-03-31 |
169 |
| 2019-12-31 |
152 |
| 2019-09-30 |
156 |
| 2019-06-30 |
146 |
| 2019-03-31 |
142 |
| 2018-12-31 |
122 |
| 2018-09-30 |
130 |
| 2018-06-30 |
119 |
| 2018-03-31 |
105 |
| 2017-12-31 |
99 |
| 2017-09-30 |
101 |
| 2017-06-30 |
98 |
| 2017-03-31 |
94 |
| 2016-12-31 |
88 |
| 2016-09-30 |
88 |
| 2016-06-30 |
86 |
| 2016-03-31 |
86 |
| 2015-12-31 |
84 |
| 2015-09-30 |
84 |
| 2015-06-30 |
83 |
| 2015-03-31 |
83 |
| 2014-12-31 |
80 |
| 2014-09-30 |
81 |
| 2014-06-30 |
77 |
| 2014-03-31 |
76 |
| 2013-12-31 |
73 |
| 2013-09-30 |
73 |
| 2013-06-30 |
73 |
| 2013-03-31 |
71 |
| 2012-12-31 |
64 |
| 2012-09-30 |
65 |
| 2012-06-30 |
63 |
| 2012-03-31 |
60 |
| 2011-12-31 |
56 |
| 2011-09-30 |
56 |
| 2011-06-30 |
55 |
| 2011-03-31 |
53 |
| 2010-12-31 |
46 |
| 2010-09-30 |
44 |
| 2010-06-30 |
44 |
| 2010-03-31 |
44 |
| 2009-12-31 |
43 |
| 2009-09-30 |
43 |
| 2009-06-30 |
42 |
| 2009-03-31 |
42 |
| Sector |
Industry |
Market Cap |
Revenue |
| Construction |
Engineering - Research & Development Services |
$0.063B |
$0.018B |
|
BioLargo Inc. is a cleantech and life sciences innovator and engineering services solution provider. The company's core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs. BioLargo Inc. is based in WESTMINSTER, CA.
|
